Screening compound: C32H37N3O4S (C530-0647)

Screening compound: C<sub>32</sub>H<sub>37</sub>N<sub>3</sub>O<sub>4</sub>S (C530-0647)
Screening compound: C<sub>32</sub>H<sub>37</sub>N<sub>3</sub>O<sub>4</sub>S (C530-0647) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C32H37N3O4S (C530-0647)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C530-0647

Molecular Formula

C32H37N3O4S (C32 H37 N3 O4 S)

Compound Name

N~8~-{3-[cyclohexyl(methyl)amino]propyl}-10-(3-methylbenzyl)-5,5,11-trioxo-10,11-dihydro-5H-5lambda~6~-dibenzo[b,f][1,4]thiazepine-8-carboxamide

IUPAC name

N-{3-[cyclohexyl(methyl)amino]propyl}-9-[(3-methylphenyl)methyl]-2210-trioxo-2lambda6-thia-9-azatricyclo[9.4.0.0^{38}]pentadeca-1(11)3(8)461214-hexaene-6-carboxamide

SMILES

Cc1cccc(CN(c(cc(cc2)C(NCCCN(C)C3CCCCC3)=O)c2S(c2c3cccc2)(=O)=O)C3=O)c1

InChI

InChI=1S/C32H37N3O4S/c1-23-10-8-11-24(20-23)22-35-28-21-25(31(36)33-18-9-19-34(2)26-12-4-3-5-13-26)16-17-30(28)40(38,39)29-15-7-6-14-27(29)32(35)37/h6-8,10-11,14-17,20-21,26H,3-5,9,12-13,18-19,22H2,1-2H3,(H,33,36)

InChI Key

QUGGZLKACUWBPY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14767724

C32H37N3O4S (C530-0647) in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with C32H37N3O4S (C530-0647) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C32H37N3O4S (C530-0647)?
Check Price and Availability of C32H37N3O4S (C530-0647), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C32H37N3O4S (C530-0647) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C32H37N3O4S (C530-0647)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C32H37N3O4S (C530-0647)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C32H37N3O4S (C530-0647) available by request